TMIS | Evolocumab + Dr. Haussler
This month in science…
We learned that evolocumab, a monoclonal antibody inhibiting proprotein convertase subtilisin-kexin type 9 (PCSK9), reduces low-density lipoprotein (LDL) cholesterol levels.
Read MoreResearch
Heat-Related Illness and Public Health
Arizona has the fortune and misfortune of being a sunny state for a significant part of the year, and the hot season is just…
Read More
SP | 3D Printing Assistive Living Devices
In the United States today, there are an estimated 30 million people living with some type of disability. While some assistive living devices, like…
Read More
Improving pediatric cancer care disparities
In 2007, the 5-year survival rate for children with acute leukemia in Baja California, Mexico was estimated at 10% (vs. 88% in the United States).
Read More